Jennifer P Macke

Title: Innovations of Jennifer P. Macke

Introduction

Jennifer P. Macke is a prominent inventor based in Columbia, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel growth factors. With a total of 3 patents, her work has implications for both diagnostic and therapeutic applications.

Latest Patents

Among her latest patents is the invention of Fibroblast Growth Factor Homologous Factor-2 (FHF-2). This patent discloses a novel growth factor, the polypeptide sequence encoding FHF-2, and the deduced amino acid sequence. Additionally, it outlines diagnostic and therapeutic methods utilizing the FHF-2 polypeptide and related polynucleotide sequences, as well as antibodies that specifically bind to FHF-2. Another significant patent is for Fibroblast Growth Factor Homologous Factor-1 (FHF-1), which includes the polypeptide sequence encoding FHF-1 and its deduced amino acid sequence. This patent also details diagnostic and therapeutic methods for using the FHF-1 polypeptide and polynucleotide sequences, along with antibodies that specifically bind to FHF-1.

Career Highlights

Jennifer P. Macke is affiliated with The Johns Hopkins University, where she continues her research and innovation in the field of growth factors. Her work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

She has collaborated with notable colleagues, including Jeremy Nathans and Philip M. Smallwood, contributing to advancements in their shared field of research.

Conclusion

Jennifer P. Macke's innovative work in the development of growth factors has positioned her as a key figure in biotechnology. Her patents reflect her commitment to advancing medical science and improving therapeutic methods.